GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adeshwar Meditex Ltd (BOM:543309) » Definitions » EBIT

Adeshwar Meditex (BOM:543309) EBIT : ₹44.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Adeshwar Meditex EBIT?

Adeshwar Meditex's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was ₹19.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹44.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Adeshwar Meditex's annualized ROC % for the quarter that ended in Sep. 2024 was 5.47%. Adeshwar Meditex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 9.54%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Adeshwar Meditex's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 14.02%.


Adeshwar Meditex EBIT Historical Data

The historical data trend for Adeshwar Meditex's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adeshwar Meditex EBIT Chart

Adeshwar Meditex Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial 44.61 45.28 31.30 48.57 45.07

Adeshwar Meditex Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.43 23.14 19.99 25.08 19.61

Competitive Comparison of Adeshwar Meditex's EBIT

For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adeshwar Meditex's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adeshwar Meditex's EV-to-EBIT falls into.


;
;

Adeshwar Meditex EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹44.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adeshwar Meditex  (BOM:543309) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Adeshwar Meditex's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=35.02 * ( 1 - 27.91% )/( (483.145 + 440.309)/ 2 )
=25.245918/461.727
=5.47 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=640.363 - 145.641 - ( 11.577 - max(0, 277.323 - 571.248+11.577))
=483.145

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=645.66 - 160.837 - ( 44.514 - max(0, 264.848 - 588.444+44.514))
=440.309

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Adeshwar Meditex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=39.224/( ( (36.392 + max(408.746, 0)) + (32.013 + max(345.273, 0)) )/ 2 )
=39.224/( ( 445.138 + 377.286 )/ 2 )
=39.224/411.212
=9.54 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(252.716 + 265.281 + 39.781) - (145.641 + 0 + 3.391)
=408.746

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(258.471 + 248.09 + 1.7689999999999) - (160.837 + 0 + 2.22)
=345.273

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Adeshwar Meditex's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=44.687/318.684
=14.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adeshwar Meditex EBIT Related Terms

Thank you for viewing the detailed overview of Adeshwar Meditex's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Adeshwar Meditex Business Description

Traded in Other Exchanges
N/A
Address
Marol Maroshi Road, Gala 111 Lok Centre, Andheri East, Marol Naka, Mumbai, MH, IND, 400059
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.

Adeshwar Meditex Headlines

No Headlines